Cargando…
Bypassing the compromised mitochondrial electron transport with methylene blue alleviates efavirenz/isoniazid-induced oxidant stress and mitochondria-mediated cell death in mouse hepatocytes
Efavirenz (EFV) is an anti-retroviral drug frequently combined with isoniazid (INH) to treat HIV-1/tuberculosis co-infected patients. Both drugs have been associated with idiosyncratic liver injury (DILI), but combined anti-retroviral and anti-tubercular therapy can increase the risk for DILI as com...
Autores principales: | Lee, Kang Kwang, Boelsterli, Urs A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297936/ https://www.ncbi.nlm.nih.gov/pubmed/25460728 http://dx.doi.org/10.1016/j.redox.2014.03.003 |
Ejemplares similares
-
Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017) -
Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
por: Yang, Luodan, et al.
Publicado: (2020) -
Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria
por: Xiong, Zheng‐Mei, et al.
Publicado: (2015) -
A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients
por: Kaboggoza, Julian P, et al.
Publicado: (2019) -
Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study
por: Mazzeffi, Michael, et al.
Publicado: (2017)